Lv2
178 积分 2022-02-05 加入
Elevated inflammatory type 2 biomarkers at baseline predict multicomponent clinical remission following dupilumab treatment in patients with moderate-to-severe asthma
7天前
已完结
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
7天前
已完结
High eosinophil counts predict decline in FEV1: results from the CanCOLD study
9天前
已完结
Peripheral eosinophil count as a biomarker for asthma exacerbation severity in acute care settings
9天前
已完结
Dupilumab Alleviates IL‐13‐Induced Nasal Epithelial Barrier Dysfunction by Regulating Claudin‐10 Expression
13天前
已完结
Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases
14天前
已完结
Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap
16天前
已完结
Eosinophil to lymphocyte ratio may predict OCS reduction and change in quality of life (AQLQ) resulting from asthma biological treatment
16天前
已完结
Different Impacts of Blood and Sputum Eosinophil Counts on Lung Function and Clinical Outcomes in Asthma: Findings from the COREA Cohort
16天前
已完结
皖公网安备34019202002308
